DECIBEL THERAPEUTICS INC's ticker is DBTX and the CUSIP is 24343R106. A total of 47 filers reported holding DECIBEL THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $157,696 | +27.5% | 40,960 | 0.0% | 0.00% | – |
| Q1 2023 | $123,699 | -14.2% | 40,960 | -41.8% | 0.00% | – |
| Q4 2022 | $144,156 | +144.3% | 70,320 | +309.8% | 0.00% | – |
| Q3 2022 | $59,000 | -18.1% | 17,160 | 0.0% | 0.00% | – |
| Q2 2022 | $72,000 | +46.9% | 17,160 | +5.5% | 0.00% | – |
| Q1 2022 | $49,000 | -32.9% | 16,260 | +3.6% | 0.00% | – |
| Q4 2021 | $73,000 | -39.7% | 15,700 | 0.0% | 0.00% | – |
| Q3 2021 | $121,000 | -81.7% | 15,700 | -73.0% | 0.00% | – |
| Q1 2021 | $661,000 | – | 58,218 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,139,685 | $10,863,000 | 4.74% |
| Samsara BioCapital, LLC | 801,629 | $2,774,000 | 0.65% |
| Orbimed Advisors | 4,945,192 | $17,110,000 | 0.32% |
| Alphabet Inc. | 1,636,258 | $5,661,000 | 0.29% |
| Newtyn Management, LLC | 300,000 | $1,038,000 | 0.23% |
| EAM Investors, LLC | 236,966 | $820,000 | 0.18% |
| HARVARD MANAGEMENT CO INC | 328,798 | $1,138,000 | 0.14% |
| Bronte Capital Management Pty Ltd. | 163,547 | $566,000 | 0.07% |
| Marquette Asset Management, LLC | 19,783 | $68,000 | 0.02% |
| ATLAS CAPITAL ADVISORS LLC | 25,000 | $86,500,000 | 0.02% |